VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 162 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,794,553 | -58.6% | 511,692 | +8.4% | 0.00% | -62.5% |
| Q2 2023 | $11,576,444 | +3.9% | 471,930 | -1.4% | 0.01% | 0.0% |
| Q1 2023 | $11,136,696 | -10.0% | 478,586 | -2.1% | 0.01% | -11.1% |
| Q4 2022 | $12,373,148 | +33.5% | 488,864 | +1.7% | 0.01% | +28.6% |
| Q3 2022 | $9,268,000 | -22.9% | 480,746 | +1.9% | 0.01% | -22.2% |
| Q2 2022 | $12,021,000 | +1694.2% | 471,935 | +1713.0% | 0.01% | – |
| Q1 2022 | $670,000 | -38.2% | 26,031 | +0.6% | 0.00% | -100.0% |
| Q4 2021 | $1,084,000 | -35.2% | 25,878 | -32.7% | 0.00% | 0.0% |
| Q3 2021 | $1,673,000 | -10.5% | 38,440 | -2.8% | 0.00% | 0.0% |
| Q2 2021 | $1,870,000 | -9.0% | 39,558 | -1.3% | 0.00% | 0.0% |
| Q1 2021 | $2,056,000 | +92.9% | 40,098 | +0.7% | 0.00% | 0.0% |
| Q4 2020 | $1,066,000 | -0.8% | 39,811 | +27.2% | 0.00% | 0.0% |
| Q3 2020 | $1,075,000 | -16.4% | 31,307 | -0.3% | 0.00% | 0.0% |
| Q2 2020 | $1,286,000 | – | 31,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |